China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc.

SXTC
China SXT Pharmaceuticals, Inc.US flagNASDAQ
2.02
USD
-0.66
- -
1.37MMarket Cap

China SXT Pharmaceuticals, Inc. (SXTC) Stock Split History

Learn about China SXT Pharmaceuticals, Inc.'s most recent 1-for-150 basis stock split on February 03, 2026. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about China SXT Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2026-02-03
Split Ratio: 1:150
Price Before Split: $0.03
Price After Split: $0.00

Developer API

Get SXTC split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/SXTC

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 150.00 times fewer shares (a 1:150 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of China SXT Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2026-02-031:150Yes$0.03$0.00
2025-02-251:8Yes$0.63$0.08
2023-10-051:25Yes$0.01$0.00
2022-05-191:20Yes$0.01$0.00
2021-02-221:4Yes$0.00$0.00

About China SXT Pharmaceuticals, Inc.

Company overview and industry information

China SXT Pharmaceuticals, Inc. (SXTC) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 1-for-150 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Drug Manufacturers - Specialty & Generic
Go to China SXT Pharmaceuticals, Inc. Summary

Last updated: 7/23/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.